Animal and in vitro data suggest that BPA has estrogenic activity [5] and disrupts several systems related to the pathogenesis of type 2 diabetes including decreased insulin sensitivity [19], dysregulation of glucose metabolism [20], altered pancreatic beta cell and hepatic cell functioning [12,20] and adiponectin release [21]. This evidence concerns the gene ADIPOQ and type 2 diabetes mellitus.